News
Montana Files Lawsuit Against OxyContin Manufacturer – One idea for preventing leftover opioids from fueling opioid abuse
The complaint, filed Nov. 30, alleges Purdue Pharma engaged in deceptive marketing practices by misrepresenting the risk of addiction, failing to disclose harmful side effects of OxyContin, claiming long-term use is safe without any evidence and claiming it was less likely to be abused.
Attorney General Tim Fox said he is seeking a court order to stop Purdue’s deceptive marketing practices along with damages incurred by the state in paying for opioids for first-line treatment of chronic pain and for treating the adverse effects of opioid use. The complaint also seeks punitive damages and civil penalties.
***
One idea for preventing leftover opioids from fueling opioid abuse
Mandating opioid manufacturers pay a few bucks per returned bottle of pills to the patient and to the drop off location operator may be what is needed to make returning leftover medication as automatic and prevalent as recycling cans and bottles.
By Keith Humphreys
MATR Supporters (view all)
Sorry, we couldn't find any posts. Please try a different search.